Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2020 Earnings

16NovExpected
Q3 2019
Q1 2020
Q2 2020
Q3 2020
-31.5
-21.21
-10.92
-0.63

Details

Expected EPS
-24.25
Actual EPS
-27
Surprise EPS
-2.75
Surprise Percent
+11.34%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -27 per share for Q3 2020.

0 Comments

Share your thoughts